Determinants of renal afferent arteriolar actions of bradykinin: Evidence that multiple pathways mediate responses attributed to EDHF

American Journal of Physiology - Renal Physiology

Volumn 285, Issue 3 54-3, 2003, Pages

  Wang, Xuemei ^a   Trottier, Greg ^a   Loutzenhiser, Rodger ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

17 octadecynoic; Acetyl choline; Apamin; Arteriole; Charybdotoxin; Endothelium derived hyperpolarizing factor; Epoxyeicosatrienoic acids; Potassium channels; Tetraethyl ammonium

Indexed keywords

17 OCTADECYNOIC ACID; ACETYLCHOLINE; ANGIOTENSIN; APAMIN; BRADYKININ; CHARYBDOTOXIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; EPOXYICOSATRIENOIC ACID; IBUPROFEN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL; POTASSIUM CHLORIDE; PROSTAGLANDIN SYNTHASE; TETRYLAMMONIUM;

ARTERIOLE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; HYDRONEPHROSIS; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0043011665     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00127.2003     Document Type: Article

References (38)

1. Ca channels. Circulation 107: 769-776, 2003.
2. Brandes RP, Schmitz-Winnenthal FH, Feletou M, Godecke A, Huang PL, Vanhoutte PM, Fleming I, and Busse R. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci USA 97: 9747-9752, 2000.
3. Chaytor AT, Evans WH, and Griffith TM. Central role of heterocellular gap junctional communication in endothelium-dependent relaxation of rabbit arteries. J Physiol 508: 561-573, 1998.
4. + channels contribute to vascular tone. Am J Physiol Heart Circ Physiol 267: H1135-H1141, 1994.
5. Doughty JM, Plane F, and Langton PD. Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium. Am J Physiol Heart Circ Physiol 276: H1107-H1112, 1999.
6. +. Br J Pharmacol 129: 811-819, 2000.
7. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396: 269-272, 1998.
8. Edwards RM. Response of isolated renal arterioles to acetylcholine, dopamine, and bradykinin. Am J Physiol Renal Fluid Electrolyte Physiol 248: F183-F189, 1985.
9. Fisslthaler B, Popp R, Kiss L, Pontente M, Harder DR, Fleming I, and Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401: 493-496, 1999.
10. Frieden M, Sollini M, and Beny J. Substance P and bradykinin activate different types of KCa currents to hyperpolarize cultured porcine coronary artery endothelial cells. J Physiol 519: 361-371, 1999.
11. Fulton D, McGiff JC, and Quilley J. Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br J Pharmacol 107: 722-725, 1992.
12. Gebremedhin D, Harder DR, Pratt PF, and Campbell WB. Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: role of a cytochrome P450 metabolite. J Vasc Res 35: 274-284, 1998.
13. 2 in isolated perfused rat kidney. Am J Physiol Renal Physiol 285: F95-F104, 2003.
14. Hayashi K, Loutzenhiser R, Epstein M, Suzuki H, and Saruta T. Multiple factors contribute to acetylcholine-induced renal afferent arteriolar vasodilation during myogenic, norepinephrine and KCl-induced vasoconstriction, Circ Res 75: 821-828, 1994.
15. Ihara E, Hirano K, Derkach DN, Nishimura J, Nawata H, and Kanade H. The mechanism of bradykinin-induced endothelium-dependent contraction and relaxation in the porcine interbar renal artery. Br J Pharmacol 129: 943-952, 2000.
16. Imig JD, Falck JR, Wei S, and Capdevila JH. Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin. J Vasc Res 38: 247-255, 2001.
17. Imig JD, Navar LG, Roman RJ, Reddy KK, and Falck JR. Actions of epoxygenase metabolites on the preglomerular vasculature. J Am Soc Nephrol 7: 2364-2370, 1996.
18. Kuhberger E, Groschner K, Kukovetz WR, and Brunner F. The role of myoendothelial cell contact in non-nitric oxide-, non-prostanoid-mediated endothelium-dependent relaxation of porcine coronary artery. Br J Pharmacol 113: 1289-1294, 1994.
19. Langton PD, Nelson MT, Huang Y, and Standen NB. Block of calcium-activated potassium channels in mammalian arterial myocytes by tetraethylammonium ions. Am J Physiol Heart Circ Physiol 260: H927-H934, 1991.
20. Lincoln TM, Dey N, and Sellak H. Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J Appl Physiol 91: 1421-1430, 2001.
21. Loutzenhiser R. In situ studies of renal arteriolar function using the in vitro perfused hydronephrotic rat kidney. Int Rev Exper Pathol 36: 145-160, 1996.
22. Matoba T, Shimokawa H, Kubota H, Morikawa K, Fujiki T, Kunihiro I, Mukai Y, Hirakawa Y, and Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun 290: 909-913, 2002.
23. McGuire JJ, Ding H, and Triggle CR. Endothelium-derived relaxing factors: a focus on endothelium-derived hyperpolarizing factors. Can J Physiol Pharmacol 79: 443-470, 2001.
24. Nilius B and Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev 81: 1415-1459, 2001.
25. Ohlmann P, Martinez MC, Schneider F, Stoclet JC, and Andriantsitohaina R. Characterization of endothelium-derived relaxing factors released by bradykinin in human resistance arteries. Br J Pharmacol 121: 657-664, 1997.
26. Pompermayer K, Assreuy J, and Vieira MA. Involvement of nitric oxide and potassium channels in the bradykinin-induced vasodilatation in the rat kidney perfused ex situ. Regul Pept 105: 155-162, 2002.
27. Quilley J, Fulton D, and McGiff JC. Hyperpolarizing factors. Biochem Pharmacol 54: 1059-1070, 1997.
28. Quilley J and McGiff JC. Is EDHF an epoxyeicosatrienoic acid? Trends Pharmacol Sci 21: 121-124, 2000.
29. Rapacon M, Mieyal P, McGiff JC, Fulton D, and Quilley J. Contribution of calcium-activated potassium channels to the vasodilator effect of bradykinin in the isolated, perfused kidney of the rat. Br J Pharmacol 118: 1504-1508, 1996.
30. Sandow SL, Tare M, Coleman HA, Hill CE, and Parkington HC. Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor. Circ Res 90: 1108-1113, 2002.
31. Schubert R and Nelson MT. Protein kinases: tuners of the BKCa channel in smooth muscle. Trends Pharmacol Sci 22: 505-512, 2001.
32. + channels. FEBS Lett 250: 519-522, 1989.
33. Strong PN. Potassium channel toxins. Pharmacol Ther 46: 137-162, 1990.
34. Triggle DR, Dong H, Waldron GJ, and Cole WC. Endothelium-derived hyperpolarizing factor(s): species and tissue heterogeneity. Clin Exp Pharmacol Physiol 26: 176-179, 1999.
35. Trottier G, Hollenberg M, Wang X, Gui Y, Loutzenhiser K, and Loutzenhiser R. Proteinase-activated receptors elicit afferent arteriolar vasodilation by NO-dependent and NO-independent actions. Am J Physiol Renal Physiol 282: F891-F897, 2002.
36. Wang X and Loutzenhiser R. Determinants of the renal microvascular response to acetylcholine: afferent and efferent arteriolar actions of EDHF. Am J Physiol Renal Physiol 282: F124-F132, 2002.
37. Yu H, Carretero OA, Juncos LA, and Garvin JL. Biphasic effect of bradykinin on rabbit afferent arterioles. Hypertension 32:287-292, 1998.
38. Zou AP, Fleming JT, Falck JR, Jacobs ER, Gebremedhin D, Harder DR, and Roman RJ. Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K-channel activity. Am J Physiol Renal Fluid Electrolyte Physiol 270: F822-F832, 1996.